RecruitingSupra-sacral Spinal Cord InjurySpinal Cord InjuryUrinary Incontinence
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
Sponsor: University of Wisconsin, Madison
You may qualify if…
- ✓ \>18 years of age
- ✓ History of supra-sacral spinal cord injury of any mechanism
- ✓ Urinary incontinence with ≥2 episodes of urinary incontinence per day (outside of spinal shock)
- ✓ Willingness to participate in drug intervention trial
- ✓ English-speaking (able to provide consent and complete questionnaires)
You may not qualify if…
- ✕ History of intravesical Botox
- ✕ Actively taking \>15 mg of Oxybutynin single dose or equivalent dose of alternative anticholinergic medication for bladder symptoms
- ✕ Use of Cannabis (any form) outside of study as determined by urine drug screen after washout period of 1 month if prior Cannabis use reported
- ✕ Thought or mood disorder aside from depression
Where it's recruiting
Wisconsin
Madison
Source: ClinicalTrials.gov · NCT06840899 · last updated 2026-03-04